成人使用13价肺炎球菌结合疫苗（Pneu-C-13）的声明：免疫国家咨询委员会（NACI）咨询委员会声明（ACS） - Suppr

Suppr

超能文献

Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13): An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

作者信息

Quach-Thanh C, Thomas Ms H

出版信息

Can Commun Dis Rep. 2013 Oct 30;39(ACS-5):1-52. doi: 10.14745/ccdr.v39i00a05.

DOI:10.14745/ccdr.v39i00a05

PMID:31682649

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6802426/

Abstract

摘要

相似文献

Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13): An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2013 Oct 30;39(ACS-5):1-52. doi: 10.14745/ccdr.v39i00a05.

Summary of the NACI Statement on Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-valent and 20-valent Conjugate Vaccines.

Can Commun Dis Rep. 2023 Feb 1;49(23):81-86.

Summary of the National Advisory Committee on Immunization's Statement on the re-immunization with polysaccharide 23-valent pneumococcal vaccine.

Can Commun Dis Rep. 2015 Apr 20;41(Suppl 3):14-16. doi: 10.14745/ccdr.v41is3a04.

Summary of NACI Statement: Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older.

Can Commun Dis Rep. 2016 Dec 1;42(12):260-262. doi: 10.14745/ccdr.v42i12a05.

An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.

Can Commun Dis Rep. 2002 Jan 15;28(ACS-2):1-32.

Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2010 Nov 23;36(ACS-12):1-21. doi: 10.14745/ccdr.v36i00a12.

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18.

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.

Can Commun Dis Rep. 2023 Oct 1;49(10):406-412. doi: 10.14745/ccdr.v49i10a01.

An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.

Can Commun Dis Rep. 2002 Feb 15;28(ACS-3):1-7.

STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-36. doi: 10.14745/ccdr.v38i00a02.

引用本文的文献

Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single-dose vaccination strategy for adults in Hong Kong.

Hum Vaccin Immunother. 2020 Aug 2;16(8):1937-1944. doi: 10.1080/21645515.2019.1711300. Epub 2020 Jan 24.

Opportunities for pharmacists in vaccinating higher-risk populations.

Can Pharm J (Ott). 2019 Oct 16;152(6):418-423. doi: 10.1177/1715163519877898. eCollection 2019 Nov-Dec.

The role of pharmacists in providing recommended vaccines.

Can Pharm J (Ott). 2019 Oct 18;152(6):406-410. doi: 10.1177/1715163519877897. eCollection 2019 Nov-Dec.

Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

Can Fam Physician. 2019 Sep;65(9):625-633.

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults.

Can J Public Health. 2018 Dec;109(5-6):756-768. doi: 10.17269/s41997-018-0050-9. Epub 2018 May 9.

Summary of NACI Statement: Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older.

Can Commun Dis Rep. 2016 Dec 1;42(12):260-262. doi: 10.14745/ccdr.v42i12a05.

A fatal case of pneumococcal sepsis years after splenectomy.

CMAJ. 2017 Jun 12;189(23):E800-E802. doi: 10.1503/cmaj.160455.

Long-term trends in invasive pneumococcal disease in Manitoba, Canada.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1884-1891. doi: 10.1080/21645515.2017.1320006. Epub 2017 May 11.

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec.

Can J Infect Dis Med Microbiol. 2017;2017:4347206. doi: 10.1155/2017/4347206. Epub 2017 Jan 26.

Whole-genome Sequencing for Surveillance of Invasive Pneumococcal Diseases in Ontario, Canada: Rapid Prediction of Genotype, Antibiotic Resistance and Characterization of Emerging Serotype 22F.

Front Microbiol. 2016 Dec 27;7:2099. doi: 10.3389/fmicb.2016.02099. eCollection 2016.

本文引用的文献

Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2010 Nov 23;36(ACS-12):1-21. doi: 10.14745/ccdr.v36i00a12.

Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.

PLoS One. 2012;7(9):e46133. doi: 10.1371/journal.pone.0046133. Epub 2012 Sep 28.

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

Can J Microbiol. 2012 Aug;58(8):1008-17. doi: 10.1139/w2012-073. Epub 2012 Jul 24.

Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.

Clin Vaccine Immunol. 2012 Aug;19(8):1296-303. doi: 10.1128/CVI.00176-12. Epub 2012 Jun 27.

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.

BMC Infect Dis. 2011 Nov 11;11:314. doi: 10.1186/1471-2334-11-314.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.

Pediatr Infect Dis J. 2012 Jan;31(1):72-7. doi: 10.1097/INF.0b013e318233049d.

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.

Vaccine. 2011 Jul 18;29(32):5195-202. doi: 10.1016/j.vaccine.2011.05.031. Epub 2011 May 25.

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

J Infect Dis. 2010 Oct 1;202(7):1114-25. doi: 10.1086/656147.

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.

AIDS. 2010 May 15;24(8):1226-8. doi: 10.1097/QAD.0b013e3283389de5.

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

N Engl J Med. 2010 Mar 4;362(9):812-22. doi: 10.1056/NEJMoa0903029.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验